| scholarly article | Q13442814 |
| P50 | author | Sarah M R Wille | Q79902061 |
| Christophe Stove | Q40479091 | ||
| P2093 | author name string | Willy E Lambert | |
| Nele Samyn | |||
| Ann-Sofie M E Ingels | |||
| P2860 | cites work | Optimization of protein precipitation based upon effectiveness of protein removal and ionization effect in liquid chromatography-tandem mass spectrometry | Q28205578 |
| Bioanalytical procedures for determination of drugs of abuse in blood | Q28299907 | ||
| Gamma-hydroxybutyrate withdrawal syndrome | Q31928136 | ||
| Recent trends in analytical procedures in forensic toxicology | Q33231326 | ||
| Dose-dependent absorption and elimination of gamma-hydroxybutyric acid in healthy volunteers. | Q51676075 | ||
| Circadian Rhythm in Plasma Concentrations of Gamma-Hydroxybutyric Acid in Alcoholics | Q51866261 | ||
| Intoxications due to ingestion of gamma-butyrolactone: organ distribution of gamma-hydroxybutyric acid and gamma-butyrolactone | Q33372725 | ||
| Determination of gamma-hydroxybutyric acid in serum and urine by headspace solid-phase dynamic extraction combined with gas chromatography-positive chemical ionization mass spectrometry | Q33423367 | ||
| Gamma-hydroxybutyrate in urine and serum: additional data supporting current cut-off recommendations | Q33563821 | ||
| Prevalence of drugs used in cases of alleged sexual assault | Q33864897 | ||
| Simultaneous screening for and determination of 128 date-rape drugs in urine by gas chromatography-electron ionization-mass spectrometry | Q34102468 | ||
| Case series of 226 γ-hydroxybutyrate–associated deaths: lethal toxicity and trauma | Q34136809 | ||
| The clinical toxicology of γ-hydroxybutyrate, γ-butyrolactone and 1,4-butanediol | Q34285013 | ||
| LC-MS vs. GC-MS, online extraction systems, advantages of technology for drug screening assays | Q34327708 | ||
| Uptake of gamma-valerolactone--detection of gamma-hydroxyvaleric acid in human urine samples | Q34332721 | ||
| Analysis of GHB and 4-methyl-GHB in postmortem matrices after long-term storage | Q34408561 | ||
| Gamma hydroxybutyric acid (GHB) concentrations in humans and factors affecting endogenous production | Q34533565 | ||
| Epidemiology of recreational drug toxicity in a nightclub environment. | Q34614197 | ||
| Before the injection--modern methods of sample preparation for separation techniques | Q35183395 | ||
| Gamma-hydroxybutyrate: bridging the clinical-analytical gap. | Q35857762 | ||
| Position of chromatographic techniques in screening for detection of drugs or poisons in clinical and forensic toxicology and/or doping control. | Q35970376 | ||
| Trends in gamma-hydroxybutyrate (GHB) and related drug intoxication: 1999 to 2003. | Q36375622 | ||
| Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem): differences in characteristics and misuse | Q37268694 | ||
| Quantitation of gamma-hydroxybutyric acid in dried blood spots: feasibility assessment for newborn screening of succinic semialdehyde dehydrogenase (SSADH) deficiency. | Q37436578 | ||
| Possible long-term effects of γ-hydroxybutyric acid (GHB) due to neurotoxicity and overdose | Q37985307 | ||
| Feasibility of following up gamma-hydroxybutyric acid concentrations in sodium oxybate (Xyrem®)-treated narcoleptic patients using dried blood spot sampling at home: an exploratory study. | Q39456871 | ||
| A tale of novel intoxication: seven cases of gamma-hydroxybutyric acid overdose | Q39468804 | ||
| Coma and respiratory depression following the ingestion of GHB and its precursors: three cases | Q41742762 | ||
| A rapid GC-MS determination of gamma-hydroxybutyrate in saliva | Q42171931 | ||
| Development and characterization of an enzymatic method for the rapid determination of gamma hydroxybutyric acid | Q42768704 | ||
| Determination of gamma-hydroxybutyric acid in dried blood spots using a simple GC-MS method with direct "on spot" derivatization | Q42909528 | ||
| Headspace in-tube extraction gas chromatography-mass spectrometry for the analysis of hydroxylic methyl-derivatized and volatile organic compounds in blood and urine | Q43091891 | ||
| Effect of storage temperature on endogenous GHB levels in urine | Q43620088 | ||
| Improved procedure for the analysis of gamma-hydroxybutyrate and ethylene glycol in whole blood | Q43703766 | ||
| Gamma-hydroxybutyric acid: patterns of use, effects and withdrawal | Q43752723 | ||
| GC-MS determination of gamma-hydroxybutyric acid (GHB) in blood | Q43757228 | ||
| Application of a convenient extraction procedure to analyze gamma-hydroxybutyric acid in fatalities involving gamma-hydroxybutyric acid, gamma-butyrolactone, and 1,4-butanediol | Q43765497 | ||
| Production of gamma-hydroxybutyric acid in postmortem liver increases with time after death | Q43913297 | ||
| Capillary gas chromatographic determination of 1,4-butanediol and gamma-hydroxybutyrate in human plasma and urine | Q43983649 | ||
| Rapid colorimetric screening test for gamma-hydroxybutyric acid (liquid X) in human urine | Q44041694 | ||
| Rapid and sensitive detection of urinary 4-hydroxybutyric acid and its related compounds by gas chromatography-mass spectrometry in a patient with succinic semialdehyde dehydrogenase deficiency. | Q44070981 | ||
| Determination of endogenous gamma-hydroxybutyric acid (GHB) levels in antemortem urine and blood | Q44100406 | ||
| Intra- and interindividual variations in urinary concentrations of endogenous gamma-hydroxybutyrate | Q44130473 | ||
| In vitro production of gamma-hydroxybutyrate in antemortem urine samples | Q44262007 | ||
| Validation of a simple gas chromatographic-mass spectrometric method for the determination of gamma-butyrolactone in human plasma | Q44283459 | ||
| Determination of gamma-hydroxybutyric acid in human urine by capillary electrophoresis with indirect UV detection and confirmation with electrospray ionization ion-trap mass spectrometry | Q44396989 | ||
| Forensic cases involving the use of GHB in The Netherlands | Q44438246 | ||
| Intoxication due to 1,4-butanediol | Q44466055 | ||
| Ultra-rapid procedure to test for gamma-hydroxybutyric acid in blood and urine by gas chromatography-mass spectrometry | Q44492960 | ||
| A sensitive method for 4-hydroxybutyric acid in urine using gas chromatography-mass spectrometry | Q44492977 | ||
| Stability of Plasma Gamma-Hydroxybutyrate Determined by Gas Chromatography-Positive Ion Chemical Ionization-Mass Spectrometry | Q44648299 | ||
| Determination of endogenous levels of GHB in human hair. Are there possibilities for the identification of GHB administration through hair analysis in cases of drug-facilitated sexual assault? | Q44689452 | ||
| Determination of gamma-hydroxybutyric acid in biological fluids by using capillary electrophoresis with indirect detection. | Q44708211 | ||
| Further evidence for the presence of GHB in postmortem biological fluid: implications for the interpretation of findings | Q44778708 | ||
| The possible influence of micro-organisms and putrefaction in the production of GHB in post-mortem biological fluid | Q44812117 | ||
| Applications of ion mobility spectrometry (IMS) to the analysis of gamma-hydroxybutyrate and gamma-hydroxyvalerate in toxicological matrices | Q44925091 | ||
| Liquid chromatographic-mass spectrometric determination of endogenous gamma-hydroxybutyrate concentrations in rat brain regions and plasma | Q44941034 | ||
| GHB in postmortem toxicology. Discrimination between endogenous production from exposure using multiple specimens | Q44968229 | ||
| Nonfatal instances of intoxication with gamma-hydroxybutyrate in the United Kingdom | Q44981333 | ||
| Adduct supported analysis of γ-hydroxybutyrate in human serum with LC-MS/MS. | Q45071406 | ||
| Rapid and direct analysis of gamma-hydroxybutyric acid in urine by capillary electrophoresis-electrospray ionization ion-trap mass spectrometry. | Q45143535 | ||
| Pharmacokinetics and excretion of gamma-hydroxybutyrate (GHB) in healthy subjects | Q45147663 | ||
| A reference range for endogenous gamma-hydroxybutyrate in urine by gas chromatography-mass spectrometry | Q45147672 | ||
| Simultaneous analysis of gamma-hydroxybutyric acid and its precursors in urine using liquid chromatography-tandem mass spectrometry. | Q45184616 | ||
| Forensic toxicology findings in deaths involving gamma-hydroxybutyrate | Q46219949 | ||
| Determination of gamma-hydroxybutyric acid in clinical samples using capillary electrophoresis with contactless conductivity detection | Q46297465 | ||
| Distribution of GHB in tissues and fluids following a fatal overdose | Q46654503 | ||
| A new method for the HPLC determination of gamma-hydroxybutyric acid (GHB) following derivatization with a coumarin analogue and fluorescence detection: application in the analysis of biological fluids | Q46677848 | ||
| Clinical pharmacology of 1,4-butanediol and gamma-hydroxybutyrate after oral 1,4-butanediol administration to healthy volunteers | Q46687719 | ||
| Unusually high concentrations in a fatal GHB case | Q46707616 | ||
| Gamma-hydroxybutyrate concentrations in the blood of impaired drivers, users of illicit drugs, and medical examiner cases | Q46841343 | ||
| Detection of exogenous GHB in blood by gas chromatography-combustion-isotope ratio mass spectrometry: implications in postmortem toxicology | Q46852360 | ||
| Anion exchange SPE and liquid chromatography-tandem mass spectrometry in GHB analysis | Q47248074 | ||
| Activated charcoal for GHB intoxication: an in vitro study. | Q48127762 | ||
| A hydrophilic interaction liquid chromatography electrospray tandem mass spectrometry method for the simultaneous determination of γ-hydroxybutyrate and its precursors in forensic whole blood | Q48136517 | ||
| Estimation of gamma-hydroxybutyrate (GHB) co-consumption in serum samples of drivers positive for amphetamine or ecstasy | Q48165661 | ||
| Determination of γ-hydroxybutyrate (GHB), β-hydroxybutyrate (BHB), pregabalin, 1,4-butane-diol (1,4BD) and γ-butyrolactone (GBL) in whole blood and urine samples by UPLC-MSMS. | Q48197240 | ||
| Injection port silylation of γ-hydroxybutyrate and trans-hydroxycrotonic acid: conditions optimisation and characterisation of the di-tert-butyldimethylsilyl derivatives by GC-MS. | Q48214656 | ||
| Simultaneous determination of γ-Hydroxybutyrate (GHB) and its analogues (GBL, 1.4-BD, GVL) in whole blood and urine by liquid chromatography coupled to tandem mass spectrometry | Q48297119 | ||
| Determination of gamma-hydroxybutyrate (GHB) and its precursors in blood and urine samples: a salting-out approach | Q48579868 | ||
| Abrupt awakening phenomenon associated with gamma-hydroxybutyrate use: a case series. | Q48598114 | ||
| Prevalence of gamma-hydroxybutyrate (GHB) in serum samples of amphetamine, metamphetamine and ecstasy impaired drivers | Q48611528 | ||
| A validated SPME-GC-MS method for simultaneous quantification of club drugs in human urine | Q48637481 | ||
| Gamma-hydroxybutyrate (GHB) in humans: pharmacodynamics and pharmacokinetics. | Q48643570 | ||
| Further evidence of in vitro production of gamma-hydroxybutyrate (GHB) in urine samples | Q48654129 | ||
| Determination of the illicit drug gamma-hydroxybutyrate (GHB) in human saliva and beverages by 1H NMR analysis | Q48658777 | ||
| GC-MS-MS determination of gamma-hydroxybutyrate in blood and urine | Q48677619 | ||
| Dried blood spot punches for confirmation of suspected γ-hydroxybutyric acid intoxications: validation of an optimized GC-MS procedure | Q49044992 | ||
| A sudden awakening from a near coma after combined intake of gamma-hydroxybutyric acid (GHB) and ethanol | Q49096535 | ||
| Determination of gamma-hydroxybutyric acid in biofluids using a one-step procedure with "in-vial" derivatization and headspace-trap gas chromatography-mass spectrometry | Q49126227 | ||
| Analysis of biofluids for gamma-hydroxybutyrate (GHB) and gamma-butyrolactone (GBL) by headspace GC-FID and GC-MS. | Q51379017 | ||
| Determination of gamma-hydroxybutyrate (GHB) in biological specimens by gas chromatography--mass spectrometry. | Q51420664 | ||
| Analysis of gamma-hydroxybutyrate (GHB) in urine by gas chromatography-mass spectrometry. | Q51440952 | ||
| Therapeutic gamma-hydroxybutyric acid monitoring in plasma and urine by gas chromatography-mass spectrometry. | Q51663332 | ||
| P433 | issue | 15 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | butyrolactone | Q79739 |
| P304 | page(s) | 3553-3577 | |
| P577 | publication date | 2014-02-06 | |
| P1433 | published in | Analytical and Bioanalytical Chemistry | Q2845280 |
| P1476 | title | Screening and confirmation methods for GHB determination in biological fluids | |
| P478 | volume | 406 |
| Q63246377 | A paper-based, cell-free biosensor system for the detection of heavy metals and date rape drugs |
| Q47670931 | A potential new metabolite of gamma-hydroxybutyrate: sulfonated gamma-hydroxybutyric acid |
| Q47645271 | Analysis of γ-hydroxy butyrate by combining capillary electrophoresis-indirect detection and wall dynamic coating: application to dried matrices. |
| Q86215583 | Determination of γ-hydroxybutyric acid in saliva by capillary electrophoresis coupled with contactless conductivity and indirect UV absorbance detectors |
| Q41615219 | Do capillary dried blood spot concentrations of gamma-hydroxybutyric acid mirror those in venous blood? A comparative study |
| Q35710620 | GHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome |
| Q38266513 | Methods for urine drug testing using one-step dilution and direct injection in combination with LC-MS/MS and LC-HRMS. |
| Q52305468 | Near-fatal persistent anion- and osmolal-gap acidosis due to massive gamma-butyrolactone/ethanol intoxication. |
| Q47752383 | Stability of γ-Hydroxybutyrate in Blood Samples from Impaired Drivers after Storage at 4°C and Comparison of GC-FID-GBL and LC-MS-MS Methods of Analysis |
Search more.